“But all in all, one thing we did see was that [with] the data for saw palmetto, there was a signal that does seem promising, especially when used in combination with other agents,” says Bilal Chughtai, MD.
In this video, Bilal Chughtai, MD, describes the background and key findings from the study, “Saw Palmetto Treatment for Prostatitis: A Systematic Review of the Literature,” for which he served as the senior author. Chughtai is the chief of urology at Plainview Hospital at Northwell Health in Plainview, New York.
Video Transcript:
Could you describe the background for this work?
One condition that we see a fair amount of is chronic prostatitis. It's always a particularly difficult condition to treat, mainly because of the fact that there's no great treatment options. In addition to that, a lot of these men are younger, they're looking for natural solutions. So, one of the things that we're very interested in doing is figuring out [if there are] data on natural solutions. We came across actually 21 studies discussing saw palmetto for chronic prostatitis.
What were the notable findings from this analysis?
There were 21 studies, [which] included over 1600 patients. What was remarkable was the fact that there's a huge variety in the types of saw palmettos used, in addition to the fact that a multitude of medications were used with it. Also, the end points were varied among the studies, which made it in some places a little bit difficult to compare them. But all in all, one thing we did see was that [with] the data for saw palmetto, there was a signal that does seem promising, especially when used in combination with other agents. It seems like it could be part of the cocktail for patients with chronic prostatitis.
This transcription has been edited for clarity.
Study examines patient knowledge of urinary tract infections
July 11th 2024"The objective of this study was to assess baseline knowledge about urinary tract infections, interest in health resources, and platform preferences for health information acquisition and dissemination," says Stephanie Gleicher, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.